These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 27203014)

  • 1. Risk-Sharing Agreements In Australia: Attitude Towards Risk-Sharing Arrangements With The Department Of Health For The Pbs-Listing Of Pharmaceuticals.
    Makino K; Tilden D; Kamei M; Shibata K
    Value Health; 2014 Nov; 17(7):A801. PubMed ID: 27203014
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement.
    Neumann PJ; Chambers JD; Simon F; Meckley LM
    Health Aff (Millwood); 2011 Dec; 30(12):2329-37. PubMed ID: 22147861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk-sharing schemes: a new paradigm in adopting innovative pharmaceuticals].
    Hammerman A; Greenberg D
    Harefuah; 2012 Jun; 151(6):364-7, 376. PubMed ID: 22991869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of two pharmaceutical risk-sharing agreements on pricing, promotion, and net health benefits.
    Zaric GS; Xie B
    Value Health; 2009; 12(5):838-45. PubMed ID: 19490563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aligning incentives using risk-sharing arrangements.
    Lefton R
    Healthc Financ Manage; 1997 Feb; 51(2):50-2, 54-7. PubMed ID: 10164877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance for Risk Sharing Agreements / Pay Per: Results SCHEMES FOR PHARMACEUTICALS IN CATALONIA (SPAIN).
    Mora-Ripoll R; Gilabert-Perramon A; Espinosa-Tome C; Segú L; Gasol-Boncompte M
    Value Health; 2014 Nov; 17(7):A447. PubMed ID: 27201216
    [No Abstract]   [Full Text] [Related]  

  • 8. Institutionalising cost sharing for catchment management: lessons from land and water management planning in Australia.
    Marshall GR
    Water Sci Technol; 2002; 45(11):101-11. PubMed ID: 12171341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The drug bargaining game: pharmaceutical regulation in Australia.
    Wright DJ
    J Health Econ; 2004 Jul; 23(4):785-813. PubMed ID: 15587698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative arrangements for Australian nurse practitioners: a policy analysis.
    Cashin A
    J Am Assoc Nurse Pract; 2014 Oct; 26(10):550-4. PubMed ID: 25132682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit sharing and biobanking in Australia.
    Nicol D; Critchley C
    Public Underst Sci; 2012 Jul; 21(5):534-55. PubMed ID: 23823164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target?
    Lu CY; Williams KM; Day RO
    Intern Med J; 2006 Jan; 36(1):19-27. PubMed ID: 16409309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk-sharing agreements: choice of study design and assessment criteria].
    Launois R; Ethgen O
    Ann Pharm Fr; 2013 Sep; 71(5):346-57. PubMed ID: 24075705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
    Lutsenko H; Doran CM; Hall WD
    Drug Alcohol Rev; 2008 Mar; 27(2):160-4. PubMed ID: 18264876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pharmaceutical Benefits Scheme and implications for paediatric prescribing.
    Sinha Y; Brien JA; Craig JC
    J Paediatr Child Health; 2009 Jun; 45(6):351-7. PubMed ID: 19490409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers.
    Carlson JJ; Gries KS; Yeung K; Sullivan SD; Garrison LP
    Appl Health Econ Health Policy; 2014 Jun; 12(3):231-8. PubMed ID: 24664994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Free trade in pharmaceuticals.
    Outterson MK
    Med J Aust; 2004 Sep; 181(5):260-1. PubMed ID: 15347274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying high risk groups for sexually transmitted infections and blood borne viruses upon admission to prison in Western Australia.
    Watkins RE; Mak DB; Connelly C
    Rural Remote Health; 2011; 11(2):1621. PubMed ID: 21456884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians, hospitals and health plans seek new risk-sharing arrangements.
    Capitation Manag Rep; 2005 Oct; 12(10):116-20, 109. PubMed ID: 16305048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recipient syringe sharing and its relationship to social proximity, perception of risk and preparedness to share.
    Smyth BP; Roche A
    Addict Behav; 2007 Sep; 32(9):1943-8. PubMed ID: 17258399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.